Compare RZAI & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZAI | SENS |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.4M | 397.1M |
| IPO Year | 2025 | 2014 |
| Metric | RZAI | SENS |
|---|---|---|
| Price | $2.13 | $10.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $15.08 |
| AVG Volume (30 Days) | 254.3K | ★ 830.6K |
| Earning Date | 05-11-2027 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $94.58 |
| Revenue Next Year | N/A | $51.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $2.07 | $4.79 |
| 52 Week High | $20.45 | $13.98 |
| Indicator | RZAI | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 13.53 | 62.01 |
| Support Level | N/A | $7.72 |
| Resistance Level | $11.87 | $10.64 |
| Average True Range (ATR) | 1.10 | 1.09 |
| MACD | -0.12 | 0.22 |
| Stochastic Oscillator | 2.37 | 46.44 |
Roze AI Inc is a holding company. Through its subsidiary, it operates as a disaster prevention technology company focused on the development of an AI-based technology platform called DAP (Disaster AI Platform). It is mainly involved in i) manufacturing and sales of automatic fire detector and wireless communication device and ii) the design and construction of firefighting systems. Its DAP system is a digital twin AI wireless fire system that has been installed at government facilities, military bases, designated production facilities, and power plants in Korea. The majority of the company's revenue is derived from the sales of a range of wireless fire detecting and alarming devices and systems. The company generates substantially all of its revenues from customers in Korea.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.